Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME

v3.24.1
CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME - CAD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
 [1]
Profit or loss [abstract]      
Revenues $ 48,804 $ 54,335 $ 34,053
Cost of revenues 37,974 43,044 25,458
Gross profit before fair value adjustments 10,830 11,291 8,595
Fair value adjustments:      
Unrealized change in fair value of biological assets 0 (315) 6,308
Realized fair value adjustments on inventory sold in the year (984) (1,814) (8,570)
Total fair value adjustments (984) (2,129) (2,262)
Gross profit after fair value adjustments 9,846 9,162 6,333
General and administrative expenses 11,008 21,460 17,221
Selling and marketing expenses 10,788 11,473 6,725
Restructuring expenses 617 4,383 0
Share-based compensation 225 2,637 5,422
Total operating expenses 22,638 39,953 29,368
Operating loss (12,792) (30,791) (23,035)
Finance income 7,006 6,703 23,544
Finance expenses (3,671) (1,972) (673)
Finance income (expense), net 3,335 4,731 22,871
Loss before income taxes (9,457) (26,060) (164)
Income tax expense (benefit) 771 (1,138) 500
Net loss from continuing operations (10,228) (24,922) (664)
Net loss from discontinued operations, net of tax 0 (166,379) (17,854)
Net loss (10,228) (191,301) (18,518)
Other comprehensive income that will not be reclassified to profit or loss in subsequent periods:      
Remeasurement gain on defined benefit plans 38 59 21
Exchange differences on translation to presentation currency (894) (1,238) 858
Total other comprehensive income that will not be reclassified to profit or loss in subsequent periods (856) (1,179) 879
Other comprehensive income that will be reclassified to profit or loss in subsequent periods:      
Adjustments arising from translating financial statements of foreign operation 231 (246) 530
Total other comprehensive income (loss) (625) (1,425) 1,409
Total comprehensive loss (10,853) (192,726) (17,109)
Net loss attributable to:      
Equity holders of the Company (9,498) (188,890) (17,763)
Non-controlling interests (730) (2,411) (755)
Net Loss (10,228) (191,301) (18,518)
Total comprehensive income (loss) attributable to:      
Equity holders of the Company (10,648) (190,162) (16,357)
Non-controlling interests (205) (2,564) (752)
Total comprehensive loss $ (10,853) $ (192,726) $ (17,109)
Earnings (loss) per share attributable to equity holders of the Company from continuing operations:      
Basic earnings (loss) per share (in CAD) $ (0.74) $ (3.13) $ 0.02
Diluted loss per share (in CAD) (0.74) (3.81) (3.62)
Basic loss per share (in CAD) 0 (23.17) (3.08)
Diluted loss per share (in CAD) 0 (23.17) (3.08)
Basic earnings (loss) per share (in CAD) (0.74) (26.3) (3.06)
Diluted loss per share (in CAD) $ (0.74) $ (26.98) $ (6.7)
[1] Reclassified in respect of discontinued operations - see Note 25.